- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
April 23rd, 2007
The Council for Scientific and Industrial Research (CSIR), in collaboration with international partner Ayanda Biosystems based at the Science Park of the Swiss Federal Institute of Technology in Lausanne is currently developing nanotechnology capsules for tuberculosis (TB) treatment.
Known as 'the technology of the very small', nanotechnology enables scientists to manipulate materials and particles that are a billionth of a metre, or about 1/80 000th of the diameter of a human hair.
The nanocapsules were being tested on animals, and the developers hoped that they would eventually decrease the number and frequency of drugs used by TB patients.
|Related News Press|
Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Seeing quantum motion August 30th, 2015
Draw out of the predicted interatomic force August 30th, 2015
Omni Nano and Time Warner Cable Partner to Provide Nanotechnology Education to the Boys & Girls Clubs of Los Angeles: A $10,000 Donation to Benefit Youth of Los Angeles County's Boys & Girls Clubs August 4th, 2015
Kalam: versatility personified August 1st, 2015